PHARMASENS

pharmasens-logo

PharmaSens is a focussing on the development of next-generation devices for diabetes care. Their innovative, user-friendly, patch-type devices for precise administration of insulin and for continuous glucose monitoring are designed to improve the lives of people with diabetes. These devices under broad patent protection, are extremely easy to use, painless and tubeless, and designed for low costs of manufacturing.

#SimilarOrganizations #Website #More

PHARMASENS

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2006-01-01

Address:
Reinach, Aargau, Switzerland

Country:
Switzerland

Website Url:
http://www.pharmasens.com

Total Employee:
11+

Status:
Active

Contact:
+41 61 711 0283

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Euro Google Maps Google Maps API Sectigo SSL Sectigo Domain SSL PostalAddress Schema


Similar Organizations

ascendas-genomics-logo

Ascendas Genomics

Ascendas is focused on the development of next-generation genetic testing reagents and systems.

easypharm-logo

Easypharm

Easypharm is today fully focusing on the Consumer Healthcare business and distribution in Austria.

lucilia-pharma-logo

Lucilia Pharma

Lucilia Pharma is a drug discovery company focused on exploiting the beneficial molecular properties of entities excreted/secreted.

novo-nordisk-logo

Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

okairos-logo

Okairos

Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.

pharmacure-health-care-international-ab-logo

Pharmacure Health Care International AB

Pharmacure focuses on the development of new drug to improve the therapeutic the enhancing nasal comfort of our patients.

swiss-rockets-logo

Swiss Rockets

Swiss Rockets focuses on the development of new treatment therapies and clinical drugs for cancer patients.

vitromics-healthcare-holding-bv-logo

VitrOmics Healthcare Holding BV

VitrOmics Healthcare Holding BV is focusing on the development of new diagnostic products.

Official Site Inspections

http://www.pharmasens.com

  • Host name: nova.metanet.ch
  • IP address: 80.74.156.100
  • Location: Switzerland
  • Latitude: 47.1449
  • Longitude: 8.1551
  • Timezone: Europe/Zurich

Loading ...

More informations about "PharmaSens"

We are PharmaSens

We at PharmaSens are devoted to simplifying diabetes management. We are passionate about technology bringing more people with diabetes towards better treatment and a life with โ€ฆSee details»

PharmaSens | Simplified diabetes management

PharmaSens is developing three different products to simplify diabetes management for as many people as possible using insulin. Three insulin patch pumps with a lot in common. All three โ€ฆSee details»

PharmaSens - Crunchbase Company Profile & Funding

PharmaSens is a focussing on the development of next-generation devices for diabetes care. Their innovative, user-friendly, patch-type devices for precise administration of insulin and for continuous glucose monitoring are designed โ€ฆSee details»

PharmaSens AG - LinkedIn

We at PharmaSens are devoted to simplifying diabetes management. We are passionate about technology bringing more people with diabetes towards better treatment and a life with increased freedom ...See details»

PharmaSens - Products, Competitors, Financials, Employees, โ€ฆ

Gabbay brings a wealth of research and peer-reviewed publication experience to PharmaSens at a time when the organization is undertaking extensive clinical study of its technology. The โ€ฆSee details»

PharmaSens Company Profile 2024: Valuation, Funding โ€ฆ

PharmaSens General Information Description. Developer of pharma device intended to deliver insulin safely for diabetes patients. The company designs and develops devices integrated with continuous glucose monitoring as well as โ€ฆSee details»

PharmaSens Successfully Submits FDA Approval Application for ...

Pharmasens AG +41 61 711 02 83 Aarbergstrasse 46 [email protected] 2502 Biel/Bienne www.pharmasens.com Switzerland About PharmaSens PharmaSens AG, a privately owned โ€ฆSee details»

PharmaSens Earns ISO 13485 Certification and Drives Diabetes โ€ฆ

Oct 11, 2023 PharmaSens remains well-aligned for an FDA submission slated for late 2023 . Biel/Bienne (Switzerland), November 10, 2023 . PharmaSens AG, a privately owned Swiss โ€ฆSee details»

PharmaSens - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Nov 10, 2024 The intellectual property of PharmaSens includes 25 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, โ€ฆSee details»

PharmaSens - Contacts, Employees, Board Members, Advisors

PharmaSens is a company focussing on the development of next-generation devices for diabetes care.See details»

PharmaSens: Simplifying diabetes management - We โ€ฆ

PharmaSens are leading the way in Diabetes Care management, niia essential Insulin Patch Pump has ISO 13485 Certification and is set for an FDA submission at the end of the year. We are Human partnered with PharmaSens to support โ€ฆSee details»

PharmaSens adds former ADA leaders, medtech veterans to board

Nov 6, 2024 PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.. Gabbay joins the board of the Swiss company after โ€ฆSee details»

PharmaSens AG - YouTube

We at PharmaSens are devoted to simplifying diabetes management. We are passionate about technology bringing more people with diabetes towards better treatment and a life with โ€ฆSee details»

PharmaSens seeks FDA approval for new insulin pump - Medical โ€ฆ

Jan 2, 2024 PharmaSensโ€™s semi-reusable concept of the insulin pump system aligns with cost-efficiency and sustainable design, meeting the demand for environmentally friendly products. โ€ฆSee details»

Insulin Delivery Innovator PharmaSens Appoints Robert Gabbay, โ€ฆ

Nov 6, 2024 Dr. Gabbay brings a wealth of research and peer-reviewed publication experience to PharmaSens at a time when the organization is undertaking extensive clinical study of its โ€ฆSee details»

PharmaSens Successfully Submits FDA Application for Innovative โ€ฆ

Dec 30, 2023 PharmaSens AG, a Swiss company dedicated to improving access to insulin pump therapy, has successfully submitted its FDA approval application for the revolutionary โ€ฆSee details»

News - Pharmasens

PharmaSens Earns ISO 13485 Certification and Drives Diabetes Care with Innovative niia essential Insulin Patch Pump System Media enquiries To connect with our media relations โ€ฆSee details»

PharmaSens successfully submits FDA approval application for โ€ฆ

Jan 17, 2024 PharmaSens AG has achieved a significant step in its commitment to addressing unmet needs in diabetes management. The company recently submitted its application for โ€ฆSee details»

PharmaSens Successfully Submits FDA Approval Application for

Dec 29, 2023 PharmaSens AG, a privately owned Swiss company, is dedicated to simplifying diabetes management, and broadening the reach of insulin pump therapy. The companyโ€™s โ€ฆSee details»

Our niia insulin patch pumps - Pharmasens

All the products are based on the same matchless technology. From the first niia essential pump, the standalone basal-bolus pump, to the third niia signature pump, the pump with an โ€ฆSee details»

linkstock.net © 2022. All rights reserved